ICICI Prudential Nifty Pharma Index IDCW Payout Direct Plan
SIP amount
Min. ₹1,000
Lumpsum amount
Min. ₹1,000

ICICI Prudential Nifty Pharma Index IDCW Payout Direct Plan

NAV
₹9.4563
-0.94%
(3 Feb)
AUM
8 Cr
TER
0.32%
Risk
Very High Risk
Insights
No insights found for this fund
Compare with other fund
1Y
+0.8%
+0.8%
+0.8%
-0.0%
NA
3Y
+18.3%
+18.3%
+18.3%
+16.0%
NA
5Y
+9.9%
+9.9%
+9.9%
+11.5%
NA
ALL
+9.6%
+9.6%
+9.6%
+12.0%
-4.9%
VOL
18.9%
18.9%
18.9%
16.9%
11.8%
TER
0.4%
0.4%
0.4%
0.4%
0.3%
AUM
₹496 Cr
₹496 Cr
₹496 Cr
₹2 Cr
₹8 Cr
INFO
0.51
0.51
0.51
0.71
-0.41
See fund holdings as of 31st Dec
Top holdings
Sun Pharmaceuticals Industries Ltd
25.3%
Cipla Ltd
13.6%
Dr Reddy's Laboratories Ltd
12.1%
Divi's Laboratories Ltd
10.2%
Lupin Ltd
4.1%
Alkem Laboratories Ltd
3.4%
Laurus Labs Ltd
3.4%
Torrent Pharmaceuticals Ltd
3.3%
Treps
2.9%
Aurobindo Pharma Ltd
2.9%
Top industry exposure
Healthcare
99.1%
Other information
Minimum SIP
₹1,000
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
-
Lock-in period
-
Exit load
No exit load
Fund objective
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Fund manager(s)
Kayzad Eghlim
Nishit Patel

FAQs